{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:47:12Z","timestamp":1770990432954,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.vaccine.2021.08.103","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T03:22:28Z","timestamp":1630639348000},"page":"6050-6056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Unmethylated CpG motif-containing genomic DNA fragments of bacillus calmette-guerin improves immune response towards a DNA vaccine for COVID-19"],"prefix":"10.1016","volume":"39","author":[{"given":"Zehua","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhui","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimeng","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifa","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aihua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2021.08.103_b0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2021.08.103_b0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.aivir.2016.08.004","article-title":"Coronavirus spike protein and tropism changes","volume":"96","author":"Hulswit","year":"2016","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2021.08.103_b0015","doi-asserted-by":"crossref","first-page":"100673","DOI":"10.1016\/j.nmni.2020.100673","article-title":"Mutated COVID-19 may foretell a great risk for mankind in the future","volume":"35","author":"Dawood","year":"2020","journal-title":"New Microbes New Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.103_b0020","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.vaccine.2021.08.103_b0025","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201312","article-title":"A virus that has gone viral: amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity","volume":"40","author":"Saha","year":"2020","journal-title":"Biosci Rep"},{"key":"10.1016\/j.vaccine.2021.08.103_b0030","doi-asserted-by":"crossref","first-page":"104351","DOI":"10.1016\/j.meegid.2020.104351","article-title":"Emergence of genomic diversity and recurrent mutations in SARS-CoV-2","volume":"83","author":"van Dorp","year":"2020","journal-title":"Infect Genet Evol"},{"issue":"8","key":"10.1016\/j.vaccine.2021.08.103_b0035","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13525","article-title":"SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate","volume":"74","author":"Becerra-Flores","year":"2020","journal-title":"Int J Clin Pract"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2021.08.103_b0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12026-008-8076-3","article-title":"DNA vaccines: developing new strategies to enhance immune responses","volume":"42","author":"Abdulhaqq","year":"2008","journal-title":"Immunol Res"},{"issue":"3","key":"10.1016\/j.vaccine.2021.08.103_b0045","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14760584.2016.1124762","article-title":"Molecular mechanisms for enhanced DNA vaccine immunogenicity","volume":"15","author":"Li","year":"2016","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.103_b0050","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4049\/jimmunol.171.1.212","article-title":"Plasmacytoid dendritic cell-derived IFN-alpha induces TNF-related apoptosis-inducing ligand\/Apo-2L-mediated antitumor activity by human monocytes following CpG oligodeoxynucleotide stimulation","volume":"171","author":"Kemp","year":"2003","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2021.08.103_b0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1753425919879997","article-title":"Unmethylated CpG motif-containing genomic DNA fragment of Bacillus calmette-guerin promotes macrophage functions through TLR9-mediated activation of NF-kappaB and MAPKs signaling pathways","volume":"26","author":"Li","year":"2020","journal-title":"Innate Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.103_b0060","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/22221751.2020.1743767","article-title":"Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2","volume":"9","author":"Nie","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.103_b0065","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/s41467-020-16505-0","article-title":"Immunogenicity of a DNA vaccine candidate for COVID-19","volume":"11","author":"Smith","year":"2020","journal-title":"Nat Commun"},{"issue":"6505","key":"10.1016\/j.vaccine.2021.08.103_b0070","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.abc6284","article-title":"DNA vaccine protection against SARS-CoV-2 in rhesus macaques","volume":"369","author":"Yu","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.103_b0075","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"10","author":"Bode","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2021.08.103_b0080","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1084\/jem.194.6.863","article-title":"Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens","volume":"194","author":"Kadowaki","year":"2001","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.vaccine.2021.08.103_b0085","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1002\/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H","article-title":"Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12","volume":"31","author":"Krug","year":"2001","journal-title":"Eur J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2021.08.103_b0090","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.4049\/jimmunol.166.8.5000","article-title":"Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells","volume":"166","author":"Bauer","year":"2001","journal-title":"J Immunol"},{"issue":"6813","key":"10.1016\/j.vaccine.2021.08.103_b0095","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.vaccine.2021.08.103_b0100","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.167.7.3555","article-title":"Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells","volume":"167","author":"Takeshita","year":"2001","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2021.08.103_b0105","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1189\/jlb.71.5.813","article-title":"Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide","volume":"71","author":"Gursel","year":"2002","journal-title":"J Leukoc Biol"},{"issue":"9","key":"10.1016\/j.vaccine.2021.08.103_b0110","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","article-title":"Quantitative expression of toll-like receptor 1\u201310 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides","volume":"168","author":"Hornung","year":"2002","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2021.08.103_b0115","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.vaccine.2021.02.003","article-title":"Avidity assay to test functionality of anti-SARS-Cov-2 antibodies","volume":"39","author":"Gaspar","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.08.103_b0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijid.2021.01.061","article-title":"The potential significance of high avidity immunoglobulin G (IgG) for protective immunity towards SARS-CoV-2","volume":"106","author":"Bauer","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2021.08.103_b0125","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.cell.2020.07.024","article-title":"A thermostable mRNA vaccine against COVID-19","volume":"182","author":"Zhang","year":"2020","journal-title":"Cell"},{"issue":"6510","key":"10.1016\/j.vaccine.2021.08.103_b0130","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1126\/science.abc5881","article-title":"Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody","volume":"369","author":"Lv","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.103_b0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41564-020-00824-5","article-title":"Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals","volume":"6","author":"Zhang","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2021.08.103_b0140","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial","author":"Xia","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2021.08.103_b0145","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00011-020-01377-3","article-title":"SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus","volume":"69","author":"Oberemok","year":"2020","journal-title":"Inflamm Res"},{"issue":"8","key":"10.1016\/j.vaccine.2021.08.103_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000003","article-title":"Why are RNA virus mutation rates so damn high?","volume":"16","author":"Duffy","year":"2018","journal-title":"PLoS Biol."},{"issue":"7","key":"10.1016\/j.vaccine.2021.08.103_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001005","article-title":"Quasispecies theory and the behavior of RNA viruses","volume":"6","author":"Lauring","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2021.08.103_b0160","doi-asserted-by":"crossref","unstructured":"Zhou B et al. SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibility. bioRxiv; 2020.","DOI":"10.1101\/2020.10.27.357558"},{"key":"10.1016\/j.vaccine.2021.08.103_b0165","article-title":"Spike mutation D614G alters SARS-CoV-2 fitness","author":"Plante","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vaccine.2021.08.103_b0170","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.103_b0175","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.26.1.2002106","article-title":"Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020","volume":"26","author":"Leung","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2021.08.103_b0180","unstructured":"Tegally H et al. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv; 2020. p. 2020.12.21.20248640."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21011658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21011658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:00:03Z","timestamp":1759402803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21011658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":36,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0264410X21011658"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.103","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmethylated CpG motif-containing genomic DNA fragments of bacillus calmette-guerin improves immune response towards a DNA vaccine for COVID-19","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}